Big pharma, Partnering

Merck KGaA and BeiGene collaborate in co-promotion agreement

Posted on 03 June 2013

Tags: , ,

BeiGene and Merck KGaA, a top big pharma company  have entered into a global licensing, co-development, co promotion and commercialization agreement for BeiGene-283.

The compound is a second-generation BRAF inhibitor for the treatment of cancer.

BeiGene-283,which is currently in preclinical development, was discovered and developed in the People’s Republic of China by BeiGene.

It is expected to enter clinical development next year.

Under the terms of this development and co promotion collaboration, BeiGene will be responsible for the  development and commercialization of BeiGene-283 in the People’s Republic  of China and Merck KGaA will be responsible for the development and  commercialization of BGB-283 for the rest of the world.

BeiGene will receive an undisclosed upfront payment and is eligible to receive further payments of up to US$ 233 million for the achievement of clinical development and potential commercial milestones in both the People’s Republic of China and rest of the world, as well as up to double digit royalties on net sales.

For further deal information visit Current Agreements (subscription required)


Read: more on partnering deals in pharma, biotech, life science partnering deal news, insights and glossary

Read: Big pharma deal news- latest deal news for top 50 pharma / big pharma companies

Report: Practical Guide to Finding Partners

Report: Partnering Deals and Alliances with Big Pharma 

Report: Partnering Deals and Alliances with Merck KgaA / Merck Serono

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply